Stephan Jackman
Vermogen: 80 $ op 31-08-2026
Vermogen: 80 $ op 31-08-2026
Mr. Stephan Jackman is a Chief Executive Officer & Director at Alzamend Neuro, Inc. He is on the Board of Directors at Alzamend Neuro, Inc. Mr. Jackman was previously employed as a Chief Operating Officer by Exit 9 Technologies, Inc. and a Chief Operating Officer by Ennaid Therapeutics LLC.
He received his undergraduate degree from Stevens Institute of Technology and a graduate degree from Stevens Institute of Technology.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ALZAMEND NEURO, INC. 0,01% | 22-07-2026 | 50 ( 0,01% ) | 80 $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ALZAMEND NEURO, INC. | Algemeen Directeur | 20-11-2018 |
| Bedrijven | Functie | Einde |
|---|---|---|
Exit 9 Technologies, Inc.
Exit 9 Technologies, Inc. Information Technology ServicesTechnology Services Exit 9 Technologies, Inc. operates in the software industry and employs between 20 and 49 people, generating revenue between $500,000 and $1 million. The private company is based in Marietta. | Operationeel Directeur | 01-11-2018 |
Ennaid Therapeutics LLC
Ennaid Therapeutics LLC BiotechnologyHealth Technology Operates as a health care based biotechnology firm that develops drugs to treat emerging, infectious diseases and virus | Operationeel Directeur | 01-10-2017 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Stevens Institute of Technology
Stevens Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alzamend Neuro, Inc.
Alzamend Neuro, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Ennaid Therapeutics LLC
Ennaid Therapeutics LLC BiotechnologyHealth Technology Operates as a health care based biotechnology firm that develops drugs to treat emerging, infectious diseases and virus | Health Technology |
Exit 9 Technologies, Inc.
Exit 9 Technologies, Inc. Information Technology ServicesTechnology Services Exit 9 Technologies, Inc. operates in the software industry and employs between 20 and 49 people, generating revenue between $500,000 and $1 million. The private company is based in Marietta. | Technology Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau